Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia
Clinical trial NCT04606433 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04606433
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-04
- Primary completion
- 2025-12-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.